Beijing Jiacheng Biomedical Technology Development Co., Ltd

Explore the PK characteristics of SY002 tablets in humans and compare the differences in pharmacokinetics between SY002 tablets and control preparations in humans. Study the safety of the test preparation SY002 tablets and control preparations in healthy adult subjects (including adverse events, serious adverse events, vital signs, physical examinations, laboratory tests, 12-lead electrocardiograms, etc.).

The main purpose of the study is to evaluate the pharmacokinetic differences between JC002 and the control formulation in the postprandial state and the effect of a high-fat meal on pharmacokinetics. The secondary purpose of the study is to study the safety of the test formulation and the control formulation in healthy adult subjects.

The main purpose of the study is to evaluate the pharmacokinetic characteristics of JC002 in the fasting state. The secondary purpose of the study is to evaluate whether the taste of JC002 is different from that of the marketed control preparation; and to observe the safety of JC002 in healthy adult subjects.